mRNA Safety - Search News

FDA Approves 1st mRNA Flu Vaccine

The American Journal of Managed Care · 2d

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

The FDA approved Moderna’s Biologics License Application (BLA) for its mRNA-based flu vaccine, mRNA-1010 (mFlusiva; Moderna), for adults 50 years and older, supported by a unanimous recommendation from the Vaccines and Related Biological Products Advisory Committee (VRBPAC) and superior efficacy trial data. 1

Opinion

· 2d

FDA Approval Of Moderna’s mRNA Flu Vaccine Is Great News. Here’s Why

Everyday Health on MSN · 13h

FDA approves first mRNA flu vaccine for adults 50 and older

Science News · 1d

Here’s what the first mRNA flu vaccine could mean for flu season

mRNA flu shots have officially arrived.

· 1d

A new flu vaccine geared to older people is coming soon

· 17h

The flu shot is about to change forever. Here’s why.

New Atlas · 1d

First mRNA flu vaccine has been approved for US adults

The FDA voted unanimously to make mFluvisa available for those in the 50-64 age bracket based on the drug's most recent Phase 3 results.

WPBF · 1d

FDA approves first mRNA-based flu vaccine

· 1d

Moderna mRNA flu shot wins FDA approval but awaits CDC recommendations

NBC 7 San Diego

Fact check: HHS misleads on mRNA vaccine safety after pulling Moderna funding

The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety of mRNA technology, despite an extensive history of testing. “After a rigorous review, we concluded that continued investment in ...

Hosted on MSN

What are mRNA vaccines, and what is the impact of RFK Jr. slashing $500M to research them?

When U.S. Health Secretary Robert F. Kennedy Jr. announced on Aug. 5 that nearly $500 million to research mRNA vaccines would be canceled, it was one in a continuing line of moves that have put his long-held vaccine skepticism into public policy even ...

The American Journal of Managed Care

Updated mRNA Vaccines Against JN.1 Show Strong Safety Signal in Real-World Data

The Danish cohort study found no significant increase in serious adverse events following JN.1-containing mRNA COVID-19 vaccines, reinforcing their safety profile. Key findings include reduced risks for ischemic cardiac events, cerebrovascular events, and ...

News Medical

Safety surveillance suggests that COVID-19 mRNA vaccination is safe for young children

In a recent article published in Pediatrics, researchers presented the results of their rapid cycle analysis (RCA) safety surveillance, which is a weekly surveillance monitoring of monovalent messenger ribonucleic acid (mRNA) coronavirus disease 2019 ...